Streetbeat News

Stock Prices

BCAB

BioAtla (NASDAQ:BCAB) reported a Q2 2024 GAAP EPS of $(0.44), which met the analyst consensus estimate.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:27 pm

U

Unity Software (NYSE:U) reported Q2 2024 GAAP EPS of $(0.32), beating the estimate of $(0.41). Sales were $449.259M, surpassing the $439.451M estimate. However, sales decreased by 15.79% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:27 pm

ARM

IWM

MRVL

QQQ

SPY

The S&P 500 closed 2.3% higher, marking its best session since January 2023, driven by lower-than-expected jobless claims. The Nasdaq 100 rose 3.1%, with Arm Holdings and Marvell Technologies leading gains. Fed's Barkin downplayed unemployment concerns, indicating a cautious but steady economic normalization.

Portfolio Pulse from Piero Cingari

August 08, 2024 | 8:27 pm

ONTO

Onto Innovation shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:26 pm

LPRO

Open Lending (NASDAQ:LPRO) reported Q2 2024 earnings of $0.02 per share, missing the analyst estimate of $0.05 by 60%. Sales were $26.7M, missing the $31.033M estimate by 13.96% and down 30.02% from last year's $38.154M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:26 pm

MITK

Mitek Systems (NASDAQ:MITK) reported Q3 2024 adjusted EPS of $0.25, missing the analyst estimate of $0.26. Quarterly sales were $44.976 million, also missing the estimate of $47.986 million. Despite the misses, sales increased by 4.43% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:26 pm

DXC

DXC Technology reported Q1 2025 adjusted EPS of $0.74, beating the analyst estimate of $0.58. Quarterly sales were $3.236 billion, surpassing the $3.140 billion estimate but reflecting a 6.09% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:26 pm

GILD

Gilead Sciences has raised its FY24 adjusted EPS forecast from $3.45 - $3.85 to $3.60 - $3.90, with an estimated $3.75. The product sales outlook remains unchanged.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:25 pm

PARA

PARAA

Paramount Global shares are trading higher following Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:25 pm

VIAV

Viavi Solutions Inc. has provided its Q1 2025 financial guidance, forecasting net revenue between $235 million and $245 million, which is below the estimated $250.8 million. The company also expects adjusted EPS to be in the range of $0.05 to $0.07, aligning with the lower end of the estimated $0.07.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 8:25 pm